肾功能
肾病
医学
蛋白尿
内科学
肾活检
纤维化
优势比
胃肠病学
泌尿科
病理
肾
内分泌学
糖尿病
作者
Andrzej Konieczny,Piotr Donizy,Tomasz Gołębiowski,Andrzej Tukiendorf,Agnieszka Hałoń,Mariusz Kusztal,Hanna Augustyniak‐Bartosik,Magdalena Krajewska
出处
期刊:Diagnostics
[MDPI AG]
日期:2021-09-25
卷期号:11 (10): 1764-1764
被引量:10
标识
DOI:10.3390/diagnostics11101764
摘要
IgA nephropathy (IgAN) is the most frequent primary glomerulonephritis worldwide. Due to its heterogenicity, there is a need to establish robust biomarkers for IgAN, to support treatment decisions and evaluate the risk of progression to end-stage renal disease. Using both clinical and histopathological data, derived from renal biopsies, we aimed to find predictors of renal function deterioration and proteinuria reduction. Clinical and histopathological data of 80 patients with biopsy proven IgAN were analyzed. In a multivariate logarithmic regression model, the presence of endocapillary hypercellularity (E1) predicted a decline in estimated glomerular filtration rate (eGFR)of at least 50% with an odds ratio (OR) of 15.2, whereas serum albumin concentration had a negative influence on eGFR deterioration (OR 0.2). In the second multivariate model, the extent of interstitial fibrosis predicted the worsening of eGFR by 50% (OR 1.1) and serum albumin concentration had a protective impact (OR 0.1). In the univariate logarithmic regression, both the extent of interstitial fibrosis and the presence of endocapillary hypercellularity negatively correlated with the reduction in proteinuria below 1.0 g/24 h with an OR of 0.2 and 0.9, respectively. In our paper, we confirmed the utility of histopathological variables, especially endocapillary hypercellularity and interstitial fibrosis, and clinical parameters, particularly serum albumin concentration, in the prediction of both a decline in eGFR and a reduction in proteinuria in IgA nephropathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI